Showing all 2 results
Nalidixic Tablet
FreeProduct Composition & Strength
We supply this product as Uncoated or Film Coated Tablets. The formulation is engineered for rapid disintegration to ensure the active ingredient is quickly processed for renal excretion.
Active Ingredient Strength (Standard) Therapeutic Role Nalidixic Acid BP/USP 500 mg Quinolone Antibacterial Excipients Q.S. Maize Starch / Gelatin Binder & Disintegrant Coating (Optional) Q.S. HPMC / Titanium Dioxide Film Coating Ofloxacin & Satranidazole Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute stability of the fluoroquinolone and nitroimidazole APIs.
Active Ingredient Strength Primary Clinical Function Ofloxacin USP/Ph.Eur. 200 mg Broad-spectrum fluoroquinolone for the eradication of aerobic bacterial pathogens. Satranidazole INN/Ph.Eur. 300 mg Premium nitroimidazole for the eradication of anaerobic bacteria and protozoa. Excipients Microcrystalline Cellulose / Crospovidone / Magnesium Stearate / Hypromellose Diluent / Superdisintegrant / Lubricant / Premium Film-Coating (Engineered to mask bitterness and ensure immediate gastric dissolution) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for standard 3-to-5 day acute gastrointestinal and pelvic infection regimens).
